Clinical Trial

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-24; most recent amendment 2026-04-10.
Status change: Recruiting → Completed 2026-04-10
Trial Details
NCT Number NCT06954766
Lead Sponsor Chong Kun Dang Pharmaceutical
Conditions Knee Osteoarthritis
Enrollment 100 participants
Start Date 2025-04-28
Primary Completion 2025-10-28 (estimated)
Study Completion 2025-10-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-13